文献速递垂体与肾上腺疾病

两种不同的POMC启动子调控库欣病基因表达

Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

研究探讨了垂体促肾上腺皮质激素腺瘤中ACTH产生机制,通过分析11例正常垂体组织、32例ACTH分泌瘤和6例静默性促肾上腺皮质激素腺瘤,发现POMC基因内含子2/外显子3交界处存在第二个启动子,其甲基化状态与临床表型相关,并受CREB调控。

要点

  • POMC基因存在第二个启动子,位于内含子2/外显子3交界处,兼具增强子功能。
  • 第二个启动子甲基化程度与ACTH分泌肿瘤类型相关:静默瘤高甲基化,分泌瘤低甲基化。
  • 第一个启动子仅在USP8突变垂体ACTH瘤中高度去甲基化。

核心结论

  • 鉴定出第二个POMC启动子,其甲基化状态调控ACTH分泌性垂体瘤的基因表达。

研究设计与样本

  • 研究分析了11例正常人类垂体组织、32例ACTH分泌肿瘤和6例静默性促肾上腺皮质激素腺瘤。

主要发现

  • 第二个启动子位于内含子2/外显子3交界处,体外实验显示CREB结合并调控其转录活性。
  • 第二个启动子在静默性促肾上腺皮质激素腺瘤中高度甲基化,在正常垂体组织中部分去甲基化,在垂体及异位ACTH分泌肿瘤中高度去甲基化。
  • 第一个启动子在所有表达POMC的细胞中去甲基化,仅在携带USP8突变的垂体ACTH分泌肿瘤中高度去甲基化。
  • 第二个启动子的去甲基化模式与库欣病的临床表型相关。

临床怎么用

  • 第二个POMC启动子可能成为抑制ACTH过度产生的治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Mechanisms underlying pituitary corticotroph adenoma adrenocorticotropin (ACTH) production are poorly understood, yet circulating ACTH levels closely correlate with adenoma phenotype and clinical outcomes. OBJECTIVE: We characterized the 5' ends of proopiomelanocortin (POMC) gene transcripts, which encode the precursor polypeptide for ACTH, in order to investigate additional regulatory mechanisms of POMC gene transcription and ACTH production. METHODS: We examined 11 normal human pituitary tissues, 32 ACTH-secreting tumors, as well as 6 silent corticotroph adenomas (SCAs) that immunostain for but do not secrete ACTH. RESULTS: We identified a novel regulatory region located near the intron 2/exon 3 junction in the human POMC gene, which functions as a second promoter and an enhancer. In vitro experiments demonstrated that CREB binds the second promoter and regulates its transcriptional activity. The second promoter is highly methylated in SCAs, partially demethylated in normal pituitary tissue, and highly demethylated in pituitary and ectopic ACTH-secreting tumors. In contrast, the first promoter is demethylated in all POMC-expressing cells and is highly demethylated only in pituitary ACTH-secreting tumors harboring the ubiquitin-specific protease 8 (USP8) mutation. Demethylation patterns of the second promoter correlate with clinical phenotypes of Cushing disease. CONCLUSION: We identified a second POMC promoter regulated by methylation status in ACTH-secreting pituitary tumors. Our findings open new avenues for elucidating subcellular regulation of the hypothalamic-pituitary-adrenal axis and suggest the second POMC promoter may be a target for therapeutic intervention to suppress excess ACTH production.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Araki T, Tone Y, Yamamoto M, et al. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease. J Clin Endocrinol Metab. 2021. PMID: 34061962. doi:10.1210/clinem/dgab387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。